Tenille Davis, a pharmacist with the Alliance for Pharmacy Compounding, likened the FDAs attempts to restrict gray market suppliers to an unending game of Whac-a-Mole. Meanwhile, clinicians like endocrinologist Edwin Lee, a co-founder of the Clinical Peptide Society, have campaigned for broader clinical access to peptides such as BPC-157 and thymosin alpha-1, arguing that current FDA restrictions limit treatment options despite growing clinician interest
While extensive animal studies exist, human data is extremely limited and lacks rigorous clinical trials
Your Goal Start by selecting your wellness goal or main area of focus
[2] Madzarac, Goran , et al
Imagine waking up and feeling like gravity has suddenly doubled
Ever feel like your internal battery is stuck at 20%